跳至主要内容
临床试验/NCT01213784
NCT01213784已完成2 期

Optimized Glycemic Control in Type 2 Diabetics With Heart Failure:"Effect on Left Ventricular Function and Skeletal Muscle"

University of Aarhus1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2010年9月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
40
试验地点
1
主要终点
Left ventricular function

研究概览

简要总结

The investigators wish to investigate wether a more strict diabetic control improves cardiac function, muscle strength, exercise capacity and decreases symptoms.

The investigators hypothesis is that improving the glycemic control in suboptimized diabetics with heart failure will improve cardiac performance, muscle strength, exercise capacity and decrease symptoms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Ejection fraction =<45%
  • •Hba1c =>7,5%
  • •In anticongestive treatment
  • •NYHA class 2-4

排除标准

  • •Severe angina (CCS 3-4)
  • •Hemodynamic significant heart valve disease
  • •Congenital heart disease
  • •Pregnancy

研究组 & 干预措施

optimized diabetic control

Experimental

each participant will be assigned to be optimized in a dedicated diabetic clinic

干预措施: all antidiabetic drugs will be appliable (Other)

control

No Intervention

participants will be assigned to follow what ever control they were in before the study and not to change any antidiabetic treatment during the interventions period.

结局指标

主要结局

Left ventricular function

时间窗: 4 month

Left ventricular function will be evaluated using echocardiografi measuring: - 2D Ejection fraction (using an ultrasound agent), global and regional tissue velocity, Strain / strain rate - all measures done during rest and dobutamin stress test.

次要结局

  • Exercise capacity and peak oxygen consumption(4 month)
  • 6-minutes hall walk test(4 month)
  • hormonal and metabolic profile(4 month)
  • Muscle strength and mass(4 month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验